FDA Guidance Encourages Companies To Include Patient Preferences In Submissions

The US FDA has issued a draft guidance document providing recommendations on how device firms can collect patient preference data to share with the agency as it reviews applications. The current draft supersedes final guidance the agency published in 2016.